NIPPON CHEMIPHAR CO., LTD. (4539) Balance sheet

Market cap
¥6.6B
P/E ratio
93.5x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/032026/03
Cash and cash equivalents -5,8807,2238,1697,9699,33310,07910,58411,64510,5299,2007,0215,342
Accounts receivable, net-12,79814,2419,8868,4387,9637,3687,9788,1007,5167,7368,2688,179
Inventories-3,3673,6524,0144,1644,3514,4004,7204,9426,4685,7855,9117,035
Total current assets-24,84427,37829,00928,33428,66829,31430,44633,49533,43631,83630,06629,941
Property, plant and equipment, net-12,94112,91714,70714,54913,79013,18512,30911,84811,51813,22414,73714,279
Marketable securities, non-current -2,4282,3022,4122,9012,8691,8532,0261,8101,3852,0661,9232,071
Total non-current assets-16,58316,26317,99118,47918,25616,54716,67615,95715,13417,71219,78520,037
Total assets -41,42843,64447,00246,81446,92645,86247,12449,45348,57149,54849,85149,978
Accounts payable-3,9742,0871,7611,7651,9261,7451,7772,1462,5452,0202,3681,868
Short-term debt-476500496476432400384400392568230174
Long-term debt, current -2,5233,5592,3712,4552,4952,6602,4202,5812,6502,8013,1912,971
Total current liabilities-13,93915,65514,93914,91413,82513,73914,10216,75014,76613,78612,26112,696
Total non-current liabilities-11,86211,94614,70614,41215,23714,73015,00614,20215,27017,30118,42217,772
Total liabilities -25,80127,60229,64629,32629,06328,47029,10930,95230,03731,08730,68430,468
Retained earnings-7,5269,04210,70211,59612,11312,18612,65513,48213,63613,27313,43213,495
Stockholders' equity13,50115,62616,04117,35517,48717,86317,39218,01418,50118,53418,46019,16719,510
Working capital-
AI Chat